© 2025 Syngene International Limited. All rights reserved
About the Event
The BIO International Convention is the largest and most comprehensive event for biotechnology, bringing together over 20,000 leaders from across the globe. It represents the full ecosystem of biotech—from pharmaceuticals and startups to academia, non-profits, and government agencies.
At Syngene, we’re excited to be part of this global platform where innovation meets opportunity. As we navigate a time of remarkable scientific discovery, we believe biotechnology is driving positive change—transforming how we live, heal, and care for our planet. From life-saving treatments to sustainable agriculture and environmental breakthroughs, the future of biotech holds incredible promise, and we’re proud to be contributing to it.
Whether you’re a researcher, investor, or business development professional, this event offers invaluable opportunities to network, collaborate, and learn.
We look forward to seeing you there and exploring how we can work together to advance global healthcare and innovation.
Speed
- DNA to Drug Product in just 10 months
- 25+ INDs, 150+ successful projects
- US manufacturing facility with global capacity of 50000 L SUB
Innovation
- Up to 12g/L tire titer with SynWeaveTM platform
- Integrated viral testing & analytical development
- Flexible capacity for 50L to 4000L SUBs
Reliability
- ISO 27001–compliant IT systems
- Facilities approved by US FDA, EMA, ANVISA, PMDA
- GLP, AAALAC, and CAP-accredited facilities
Let’s Collaborate
Book a meeting with our experts at BIO 2025 and learn how Syngene can help you accelerate your biologics development with confidence, speed, and scientific excellence.
Peter Bains
Chief Executive Officer
Pramuch Goel
Vice President, Corporate Communication
Alex Del Priore
SVP, Manufacturing Services
Jeffery Wong
VP Sales, Biologics
Gopi Krishnan
VP, Biopharmaceutical Manufacturing
Anjan Chakrabarti
VP Sales, Research Services
Manoj Babu
VP, Development Services
Pravin Prajapati
Executive Director, Global Business Development
Patricia Caplan
Executive Director
Rajkumar Agarwal
Vice President - Business development
Vivek Kumaravel
Business Development
Shared Vision, Real Impact
Small Molecule Development and Manufacturing
Syngene offers chemical development, formulation, analytical, clinical development, and manufacturing services across small molecules, oligonucleotides, HPAPIs, and performance and specialty materials.
Clinical Development services
Syngene supports early-phase to late-phase clinical trials required for drug development programs across a wide range of therapeutic areas.
Biologics Development and Manufacturing
Syngene offers biologics development and manufacturing solutions for both mammalian and microbial systems. We also offer services from our sterile Fill-Finish facility and Viral Testing facility.
Discovery
Syngene offers integrated and standalone services across the drug discovery continuum, from Target Identification to IND enabling services.